gland pharma glp-1 capacity india How are Indian companies making money off GLP-1? Brookfield, EQT close in on

At the same time, both Lilly and Novo Nordisk made multi-billion dollar capital investments in expanding their manufacturing capacity to satisfy unrelenting patient demand, including pharmas largest M&A deal of the year, the $16.5Bn acquisition of CDMO Catalent by Novo Holdings, the controlling shareholder of Novo Nordisk

Early research and patient feedback

Over ...

Protein ingredients are gaining ground as a result of GLP-1 drugs: 21 % calories, +11 % protein

Learn which foods trigger nausea, how to adjust your diet, and when to contact your healthcare provider about food reactions during GLP-1 treatment.

GLP-1 therapies, such as Zepbound (tirzepatide), address obstructive sleep apnea by aiding weight management, thereby reducing airway pressure and improving respiratory health